These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3952005)

  • 1. The hemodynamic effects of ibopamine, a dopamine congener, in patients with congestive heart failure.
    Leier CV; Ren JH; Huss P; Unverferth DV
    Pharmacotherapy; 1986; 6(1):35-40. PubMed ID: 3952005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onset of cardiovascular action after oral ibopamine. Early hemodynamic effects of single and repeated doses in patients with idiopathic dilated myocardiopathy.
    Di Mario C; Compostella L; Iavernaro A; Libardoni M; Ghirardi P; Cucchini F
    Arzneimittelforschung; 1990 Jun; 40(6):661-6. PubMed ID: 2397001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dopamine congener, ibopamine, in congestive heart failure.
    Ren JH; Unverferth DV; Leier CV
    J Cardiovasc Pharmacol; 1984; 6(5):748-55. PubMed ID: 6209476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the acute hemodynamic effects of ibopamine and dopamine in chronic congestive heart failure.
    Sannia L; Ibba GV; Castellaccio M; Dore L
    Arzneimittelforschung; 1986 Feb; 36(2A):355-9. PubMed ID: 3707649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute haemodynamic effects of ibopamine in patients with severe congestive heart failure.
    Ghirardi P; Brusoni B; Mangiavacchi M; Bianco L; Col J; Metra M; Dei Cas L
    Br J Clin Pharmacol; 1985 May; 19(5):613-8. PubMed ID: 4005102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of ibopamine in patients with idiopathic congestive cardiomyopathy.
    Dei Cas L; Bolognesi R; Cucchini F; Fappani A; Riva S; Visioli O
    J Cardiovasc Pharmacol; 1983; 5(2):249-53. PubMed ID: 6188898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of ibopamine treatment in patients with advanced heart failure: purpose of a new therapeutic scheme with multiple daily administrations.
    Dei Cas L; Metra M; Nodari S; Visioli O
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S111-7. PubMed ID: 2483436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodynamic evaluation of ibopamine in severe congestive heart failure.
    Reffo GC; Turrin M; Gabellini A; Forattini C
    Eur J Clin Pharmacol; 1984; 26(1):19-22. PubMed ID: 6714289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of acute hemodynamic effects and pharmacokinetic behaviour of ibopamine in patients with severe heart failure.
    De Vita C; Triulzi E; Devizzi S; Colombo G; Palvarini M; Pocchiari F; Pataccini R
    Arzneimittelforschung; 1986 Feb; 36(2A):349-54. PubMed ID: 3707648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term therapy with oral ibopamine on resting hemodynamics and exercise capacity in patients with heart failure: relationship to the generation of N-methyldopamine and to plasma norepinephrine levels.
    Rajfer SI; Rossen JD; Douglas FL; Goldberg LI; Karrison T
    Circulation; 1986 Apr; 73(4):740-8. PubMed ID: 3948372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ibopamine in very severe congestive heart failure: pilot haemodynamic invasive assessment.
    Col J; Mievis E; Reynaert M
    Eur J Clin Pharmacol; 1983; 24(3):297-300. PubMed ID: 6861844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive evaluation of the effects of oral ibopamine (SB 7505) on cardiac and renal function in patients with congestive heart failure.
    Dei Cas L; Manca C; Bernardini B; Vasini G; Visioli O
    J Cardiovasc Pharmacol; 1982; 4(3):436-40. PubMed ID: 6177940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic evaluation during exercise test after acute and chronic ibopamine treatment in patients with congestive heart failure.
    Gavazzi A; Mussini A; Bramucci E
    Arzneimittelforschung; 1986 Feb; 36(2A):366-70. PubMed ID: 3707652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic advantage of combined administration of oral ibopamine and nitroprusside in patients with ischemic and idiopathic congestive cardiomyopathy.
    Dei Cas L; Fappani A; Riva S; Metra M; Cicogna R; Manca C; Visioli O
    Clin Cardiol; 1985 Aug; 8(8):427-32. PubMed ID: 4028536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic evaluation of ibopamine in patients with refractory congestive heart failure.
    Humar F; Morgera T; Maras P; Camerini F
    Arzneimittelforschung; 1986 Feb; 36(2A):360-2. PubMed ID: 3707650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic drugs in congestive heart failure: hemodynamic and neuroendocrine responses to ibopamine, dopamine, and dihydroergotoxine.
    Metra M; Missale C; Spano PF; Cas LD
    J Cardiovasc Pharmacol; 1995 May; 25(5):732-40. PubMed ID: 7630152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral hemodynamic effects of ibopamine in patients with congestive heart failure. A placebo-controlled, double-blind study.
    Longhini C; Ansani L; Musacci GF; Aggio S; Baracca E; Toselli T; Ghirardi P
    Cardiovasc Drugs Ther; 1989 Apr; 3(2):199-202. PubMed ID: 2487532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ibopamine in chronic congestive heart failure: hemodynamic and neurohumoral effects.
    López-Sendón J
    Am J Med; 1991 May; 90(5B):43S-49S. PubMed ID: 1675551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive pharmacodynamic characterization of combined ibopamine and calcium blocker therapy for heart failure.
    Munger MA; Nara AR; Pospisil RA; Stoddard GJ; Schleman M
    Pharmacotherapy; 1993; 13(3):218-23. PubMed ID: 8100627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiologic profile of ibopamine in patients with congestive heart failure and ventricular tachycardia and relation to its effects on hemodynamics and plasma catecholamines.
    Van Veldhuisen DJ; Crijns HJ; Girbes AR; Tobé TJ; Wiesfeld AC; Lie KI
    Am J Cardiol; 1991 Nov; 68(11):1194-202. PubMed ID: 1683146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.